LungScarring | Financial Buzz

Tag: LungScarring

post-image
Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Algernon Pharmaceuticals (OTCQB: AGNPF) (CSE: AGN) Lung Scarring Study

Author financial buzzPosted on
1643
FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study...
post-image
Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol

Author financial buzzPosted on
3637
Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) (CSE: AGN) (FRANKFURT: AGW) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it has decided to review...